Skip to main content
Skip to navigation
Skip to accessibility tools
Search bar
Mobile navigation
Return to main H&W ICS website
Search this site
Search
Close search bar
Home
About
About
Return to previous menu
About
Corporate
Corporate
Return to previous menu
Corporate
Governance Handbook
Publication Scheme
NHS Continuing Healthcare
Safeguarding
Safeguarding
Return to previous menu
Safeguarding
Keep me safe...
Pick up the Phone Campaign
Board Members
Meetings
Meetings
Return to previous menu
Meetings
Board papers
Past meetings
Past Board Papers
News
Documents
Contact us
Contact us
Return to previous menu
Contact us
Stakeholder and Public Liaison and Information Team
Cardiovascular
You are here:
Home
Documents
Clinical and Prescribing Policies, Guidance and Pathways
Cardiovascular
Title
Amiodarone - Prescribing Guidance v2
Anticoagulation Treatment for VTE - Prescribing Guidance v1.2
DOACs in Atrial Fibrillation - Prescribing Guidance v6.5
Dronedarone - Prescribing Guidance v2
Heart Failure - Primary Care Guidance v1.3
Primary Hypercholesterolaemia or Mixed Dyslipidaemia - PCSK9 Inhibitors Pathway v1.3
Self Monitoring Coagulation - Commissioning Policy v1.3
Varicose Veins Treatment and Surgery - Commissioning Policy v1.3
Back to Clinical and Prescribing Policies, Guidance and Pathways
National Guidance for Lipid Management
Reducing health inequalities
Digital innovation
Health and care services
Get involved
Work for us
Latest news
Accessibility tools
Show accessibility tools
Text size:
Increase text size
Decrease text size
Reset text size
Contrast:
Black and white
Blue contrast
Beige contrast
High contrast
Reset contrast
Frank Ltd.
Return to header
Last accessibility toolbar action:
none available
